Cargando…
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Hospitalised patients with coronavirus disease 2019 (COVID-19) have a high mortality rate. There are an increasing number of published randomised controlled trials for anti-inflammatory, anti-viral and other treatments. The European Respiratory Society Living Guidelines for the Management of Hospita...
Autores principales: | Crichton, Megan L., Goeminne, Pieter C., Tuand, Krizia, Vandendriessche, Thomas, Tonia, Thomy, Roche, Nicolas, Chalmers, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796659/ https://www.ncbi.nlm.nih.gov/pubmed/34911695 http://dx.doi.org/10.1183/16000617.0171-2021 |
Ejemplares similares
-
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
por: Chalmers, James D., et al.
Publicado: (2021) -
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
por: Roche, Nicolas, et al.
Publicado: (2022) -
Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
por: Tholin, Birgitte, et al.
Publicado: (2021) -
European Society of Cardiology Highlights: Late-breaking Trials – COVID-19
por: Komiyama, Maki, et al.
Publicado: (2022) -
Cardiac complications in patients hospitalised with COVID-19
por: Linschoten, Marijke, et al.
Publicado: (2020)